Zheng, Wen
Gao, Yuhuan
Ke, Xiaoyan
Zhang, Weijing
Su, Liping
Ren, Hanyun
Lin, Ningjing
Xie, Yan
Tu, Meifeng
Liu, Weiping
Ping, Lingyan
Ying, Zhitao
Zhang, Chen
Deng, Lijuan
Wang, Xiaopei
Song, Yuqin
Zhu, Jun
Article History
Received: 16 October 2017
Accepted: 29 August 2018
First Online: 21 September 2018
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Peking University Beijing Cancer Hospital Ethics Review Committee (reference number: 2011101104), and all procedures were conducted in accordance with ethical principles. The written informed consent was obtained from all individual participants included in the study. The written consent including the nature of the disease, its treatment options, and its possible outcomes was also informed to the patients registered for the study.
: Not applicable.
: The authors declare that they have no competing interests<b>.</b>
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.